1
|
Ding C, Yu H, Shi C, Shi T, Qin H and Cui
Y: MiR-let-7e inhibits invasion and magration and regulates HMGB1
expression in thyroid cancer. Biomed Pharmacother. 110:528–536.
2019. View Article : Google Scholar : PubMed/NCBI
|
2
|
Li H, Zhao L, Zhang Z, Zhang H, Ding C and
Su Z: Roles of microRNA let-7b in thyroid cancer by regulating
HMGA2. Tumour Biol. 39:10104283177192742017. View Article : Google Scholar : PubMed/NCBI
|
3
|
Huang Y, Yu S, Cao S, Yin Y, Hong S, Guan
H, Li Y and Xiao H: MicroRNA-222 promotes invasion and metastasis
of papillary thyroid cancer through targeting protein phosphatase 2
regulatory subunit b alpha expression. Thyroid. 28:1162–1173. 2018.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Gezer E, Selek A, Tarkun I, Canturk Z and
Çetinarslan B: Papillary thyroid cancer presenting as a primary
renal tumor with multiple pulmonary and bone metastases: A case
report. J Med Case Rep. 13:952019. View Article : Google Scholar : PubMed/NCBI
|
5
|
Liu C, Feng Z, Chen T, Lv J, Liu P, Jia L,
Zhu J, Chen F, Yang C and Deng Z: Downregulation of NEAT1 reverses
the radioactive iodine resistance of thyroid cancer cell via
miR-101-3p/FN1/PI3K-AKT signaling pathway. Cell Cycle. 18:167–203.
2019. View Article : Google Scholar : PubMed/NCBI
|
6
|
Xiang C, Zhang ML, Zhao QZ, Xie QP, Yan
HC, Yu X, Wang P and Wang Y: lncRNA-SLC6A9-5:2: A potent sensitizer
in 131I-resistant thyroid cancer with PARP-1 induction.
Oncotarget. 8:22954–22967. 2017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Wan ZY, Song F, Sun Z, Chen YF, Zhang WL,
Samartzis D, Ma CJ, Che L, Liu X, Ali MA, et al: Aberrantly
expressed long noncoding RNAs in human intervertebral disc
degeneration: A microarray related study. Arthritis Res Ther.
16:4652014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Chen Y, Shen Z, Zhi Y, Zhou H, Zhang K,
Wang T, Feng B, Chen Y, Song H, Wang R and Chu X: Long non-coding
RNA ROR promotes radioresistance in hepatocelluar carcinoma cells
by acting as a ceRNA for microRNA-145 to regulate RAD18 expression.
Arch Biochem Biophys. 645:117–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
9
|
Gao YT and Zhou YC: Long non-coding RNA
(lncRNA) small nucleolar RNA host gene 7 (SNHG7) promotes breast
cancer progression by sponging miRNA-381. Eur Rev Med Pharmacol
Sci. 23:6588–6595. 2019.PubMed/NCBI
|
10
|
Yao X, Liu C, Liu C, Xi W, Sun S and Gao
Z: lncRNA SNHG7 sponges miR-425 to promote proliferation,
migration, and invasion of hepatic carcinoma cells via
Wnt/β-catenin/EMT signalling pathway. Cell Biochem Funct.
37:525–533. 2019. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang J, Wang B, Ren H and Chen W: miR-9-5p
inhibits pancreatic cancer cell proliferation, invasion and
glutamine metabolism by targeting GOT1. Biochem Biophys Res Commun.
509:241–248. 2019. View Article : Google Scholar : PubMed/NCBI
|
12
|
Shi D, Wang H, Ding M, Yang M, Li C, Yang
W and Chen L: MicroRNA-26a-5p inhibits proliferation, invasion and
metastasis by repressing the expression of Wnt5a in thyroid cancer.
Onco Targets Ther. 12:6605–6616. 2019. View Article : Google Scholar : PubMed/NCBI
|
13
|
Guo F, Hou X and Sun Q: MicroRNA-9-5p
functions as a tumor suppressor in papillary thyroid cancer via
targeting BRAF. Oncol Lett. 16:6815–6821. 2018.PubMed/NCBI
|
14
|
Chen Z, Liu Z, Shen L and Jiang H: Long
non-coding RNA SNHG7 promotes the fracture repair through negative
modulation of miR-9. Am J Transl Res. 11:974–982. 2019.PubMed/NCBI
|
15
|
Wang Y, Han J, Lv Y and Zhang G: miR-29a
inhibits proliferation, invasion, and migration of papillary
thyroid cancer by targeting DPP4. Onco Targets Ther. 12:4225–4233.
2019. View Article : Google Scholar : PubMed/NCBI
|
16
|
Li C, Zhou Y, Cai Y, Shui C, Liu W, Wang
X, Jiang J, Zeng D, Gui C and Sun R: Parthenolide inhibits the
proliferation of MDA-T32 thyroid cancer cells in vitro and in mouse
tumor xenografts and activates autophagy and apoptosis by
downregulation of the mammalian target of rapamycin (mTOR)/PI3K/AKT
Signaling Pathway. Med Sci Monit. 25:5054–5061. 2019. View Article : Google Scholar : PubMed/NCBI
|
17
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Chandrashekar DS, Bashel B, Balasubramanya
SA, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BV and Varambally
S: UALCAN: A portal for facilitating tumor subgroup gene expression
and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Chehrehasa F, Meedeniya AC, Dwyer P,
Abrahamsen G and Mackay-Sim A: EdU, a new thymidine analogue for
labelling proliferating cells in the nervous system. J Neurosci
Methods. 177:122–130. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Mas-Ponte D, Carlevaro-Fita J, Palumbo E,
Hermoso Pulido T, Guigo R and Johnson R: LncATLAS database for
subcellular localization of long noncoding RNAs. RNA. 23:1080–1087.
2017. View Article : Google Scholar : PubMed/NCBI
|
23
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
24
|
Zatroch KK, Knight CG, Reimer JN and Pang
DS: Refinement of intraperitoneal injection of sodium pentobarbital
for euthanasia in laboratory rats (Rattus Norvegicus). BMC Vet Res.
13:602017. View Article : Google Scholar : PubMed/NCBI
|
25
|
Deng Y, Zhao F, Zhang Z, Sun F and Wang M:
Long noncoding RNA SNHG7 promotes the tumor growth and
epithelial-to-mesenchymal transition via regulation of miR-34a
signals in osteosarcoma. Cancer Biother Radiopharm. 33:365–372.
2018. View Article : Google Scholar : PubMed/NCBI
|
26
|
Shan Y, Ma J, Pan Y, Hu J, Liu B and Jia
L: lncRNA SNHG7 sponges miR-216b to promote proliferation and liver
metastasis of colorectal cancer through upregulating GALNT1. Cell
Death Dis. 9:7222018. View Article : Google Scholar : PubMed/NCBI
|
27
|
Li Y, Zhao L, Li N, Miao Y, Zhou H and Jia
L: miR-9 regulates the multidrug resistance of chronic myelogenous
leukemia by targeting ABCB1. Oncol Rep. 37:2193–2200. 2017.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Li Q, Chang Y, Mu L and Song Y: MicroRNA-9
enhances chemotherapy sensitivity of glioma to TMZ by suppressing
TOPO II via the NF-κB signaling pathway. Oncol Lett. 17:4819–4826.
2019.PubMed/NCBI
|
29
|
Amit M, Na'ara S, Francis D, Matanis W,
Zolotov S, Eisenhaber B, Eisenhaber F, Weiler Sagie M, Malkin L,
Billan S, et al: Post-translational regulation of radioactive
iodine therapy response in thyroid cancer. J Natl Cancer Inst. Dec
1–2017.(Epub ahead of print). doi: 10.1093/jnci/djx092. View Article : Google Scholar : PubMed/NCBI
|
30
|
Hu X, Ding D, Zhang J and Cui J: Knockdown
of lncRNA HOTAIR sensitizes breast cancer cells to ionizing
radiation through activating miR-218. Biosci Rep.
39:BSR201810382019. View Article : Google Scholar : PubMed/NCBI
|
31
|
Wang L, Xu T, Cui X, Han M, Zhou LH, Wei
ZX, Xu ZJ and Jiang Y: Downregulation of lncRNA SNHG7 inhibits
proliferation and invasion of nasopharyngeal carcinoma cells
through repressing ROCK1. Eur Rev Med Pharmacol Sci. 23:6186–6193.
2019.PubMed/NCBI
|
32
|
Sun BZ, Ji DG, Feng ZX and Wang Y: Long
noncoding RNA SNHG7 represses the expression of RBM5 to strengthen
metastasis of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci.
23:5699–5704. 2019.PubMed/NCBI
|
33
|
Wang YH, Huo BL, Li C, Ma G and Cao W:
Knockdown of long noncoding RNA SNHG7 inhibits the proliferation
and promotes apoptosis of thyroid cancer cells by downregulating
BDNF. Eur Rev Med Pharmacol Sci. 23:4815–4821. 2019.PubMed/NCBI
|
34
|
Chen K, Abuduwufuer A, Zhang H, Luo L,
Suotesiyali M and Zou Y: SNHG7 mediates cisplatin-resistance in
non-small cell lung cancer by activating PI3K/AKT pathway. Eur Rev
Med Pharmacol Sci. 23:6935–6943. 2019.PubMed/NCBI
|
35
|
Wu P, Tang Y, Fang X, Xie C, Zeng J, Wang
W and Zhao S: Metformin suppresses hypopharyngeal cancer growth by
epigenetically silencing long Non-coding RNA SNHG7 in FaDu Cells.
Front Pharmacol. 10:1432019. View Article : Google Scholar : PubMed/NCBI
|
36
|
Fan Y, Shi Y, Lin Z, Huang X, Li J, Huang
W, Shen D, Zhuang G and Liu W: miR-9-5p suppresses malignant
biological behaviors of human gastric cancer cells by negative
regulation of TNFAIP8L3. Dig Dis Sci. 64:2823–2829. 2019.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Xie CH, Cao YM, Huang Y, Shi QW, Guo JH,
Fan ZW, Li JG, Chen BW and Wu BY: Long non-coding RNA TUG1
contributes to tumorigenesis of human osteosarcoma by sponging
miR-9-5p and regulating POU2F1 expression. Tumour Biol.
37:15031–15041. 2016. View Article : Google Scholar : PubMed/NCBI
|
38
|
Wei W, Dong Z, Gao H, Zhang YY, Shao LH,
Jin LL, Lv YH, Zhao G, Shen YN and Jin SZ: MicroRNA-9 enhanced
radiosensitivity and its mechanism of DNA methylation in non-small
cell lung cancer. Gene. 710:178–185. 2019. View Article : Google Scholar : PubMed/NCBI
|
39
|
Javidroozi M, Zucker S and Chen WT: Plasma
seprase and DPP4 levels as markers of disease and prognosis in
cancer. Dis Markers. 32:309–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
40
|
Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B
and Jia L: Long non-coding RNA-SNHG7 acts as a target of miR-34a to
increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in
colorectal cancer progression. J Hematol Oncol. 11:892018.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Yi J and Gao ZF: MicroRNA-9-5p promotes
angiogenesis but inhibits apoptosis and inflammation of high
glucose-induced injury in human umbilical vascular endothelial
cells by targeting CXCR4. Int J Biol Macromol. 130:1–9. 2019.
View Article : Google Scholar : PubMed/NCBI
|
42
|
Gwak HS, Kim TH, Jo GH, Kim YJ, Kwak HJ,
Kim JH, Yin J, Yoo H, Lee SH and Park JB: Silencing of microRNA-21
confers radio-sensitivity through inhibition of the PI3K/AKT
pathway and enhancing autophagy in malignant glioma cell lines.
PLoS One. 7:e474492012. View Article : Google Scholar : PubMed/NCBI
|